Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.

A new interesting article has been published in Immunotherapy. 2020 Mar 26. doi: 10.2217/imt-2020-0067. [Epub ahead of print] Editorial and titled:

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.

Authors of this article are:

Bersanelli M.

A summary of the article is shown below:

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/32212881 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: anti-CTLA-4; COVID-19; SARS-CoV-2; anti-PD-1; anti-PD-L1; cancer patients; immune checkpoint inhibitors; immunotherapy; tocilizumab; viral infection.


New Research Kits from MOLECULAR DEPOT


New Antibodies from MOLECULAR DEPOT


New Proteins from MOLECULAR DEPOT


New Chemicals from MOLECULAR DEPOT

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.